> top > docs > PubMed:30994353 > spans > 81-279 > annotations

PubMed:30994353 / 81-279 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T2 0-198 Sentence denotes Oncogenic BRAF mutations contribute to the development of a number of cancers, and small-molecule BRAF inhibitors have been approved by the Food and Drug Administration (FDA) for anticancer therapy.
T2 0-198 Sentence denotes Oncogenic BRAF mutations contribute to the development of a number of cancers, and small-molecule BRAF inhibitors have been approved by the Food and Drug Administration (FDA) for anticancer therapy.

pubmed-enju-pas

Id Subject Object Predicate Lexical cue
EnjuParser_T11 0-9 JJ denotes Oncogenic
EnjuParser_T12 10-14 NN denotes BRAF
EnjuParser_T13 15-24 NNS denotes mutations
EnjuParser_T14 25-35 VBP denotes contribute
EnjuParser_T15 36-38 TO denotes to
EnjuParser_T16 39-42 DT denotes the
EnjuParser_T17 43-54 NN denotes development
EnjuParser_T18 55-57 IN denotes of
EnjuParser_T19 58-59 DT denotes a
EnjuParser_T20 60-66 NN denotes number
EnjuParser_T21 67-69 IN denotes of
EnjuParser_T22 70-77 NNS denotes cancers
EnjuParser_T23 77-78 -COMMA- denotes ,
EnjuParser_T24 79-82 CC denotes and
EnjuParser_T25 83-97 JJ denotes small-molecule
EnjuParser_T26 98-102 NN denotes BRAF
EnjuParser_T27 103-113 NNS denotes inhibitors
EnjuParser_T28 114-118 VBP denotes have
EnjuParser_T29 119-123 VBN denotes been
EnjuParser_T30 124-132 VBN denotes approved
EnjuParser_T31 133-135 IN denotes by
EnjuParser_T32 136-139 DT denotes the
EnjuParser_T33 140-144 NNP denotes Food
EnjuParser_T34 145-148 CC denotes and
EnjuParser_T35 149-153 NNP denotes Drug
EnjuParser_T36 154-168 NNP denotes Administration
EnjuParser_T37 169-170 -LRB- denotes (
EnjuParser_T38 170-173 NNP denotes FDA
EnjuParser_T39 173-174 -RRB- denotes )
EnjuParser_T40 175-178 IN denotes for
EnjuParser_T41 179-189 JJ denotes anticancer
EnjuParser_T42 190-197 NN denotes therapy
EnjuParser_R10 EnjuParser_T13 EnjuParser_T11 arg1Of mutations,Oncogenic
EnjuParser_R11 EnjuParser_T13 EnjuParser_T12 arg1Of mutations,BRAF
EnjuParser_R12 EnjuParser_T13 EnjuParser_T14 arg1Of mutations,contribute
EnjuParser_R13 EnjuParser_T14 EnjuParser_T15 arg1Of contribute,to
EnjuParser_R14 EnjuParser_T17 EnjuParser_T15 arg2Of development,to
EnjuParser_R15 EnjuParser_T17 EnjuParser_T16 arg1Of development,the
EnjuParser_R16 EnjuParser_T17 EnjuParser_T18 arg1Of development,of
EnjuParser_R17 EnjuParser_T20 EnjuParser_T18 arg2Of number,of
EnjuParser_R18 EnjuParser_T20 EnjuParser_T19 arg1Of number,a
EnjuParser_R19 EnjuParser_T20 EnjuParser_T21 arg1Of number,of
EnjuParser_R20 EnjuParser_T22 EnjuParser_T21 arg2Of cancers,of
EnjuParser_R21 EnjuParser_T24 EnjuParser_T23 arg1Of and,","
EnjuParser_R22 EnjuParser_T14 EnjuParser_T24 arg1Of contribute,and
EnjuParser_R23 EnjuParser_T30 EnjuParser_T24 arg2Of approved,and
EnjuParser_R24 EnjuParser_T27 EnjuParser_T25 arg1Of inhibitors,small-molecule
EnjuParser_R25 EnjuParser_T27 EnjuParser_T26 arg1Of inhibitors,BRAF
EnjuParser_R26 EnjuParser_T27 EnjuParser_T28 arg1Of inhibitors,have
EnjuParser_R27 EnjuParser_T30 EnjuParser_T28 arg2Of approved,have
EnjuParser_R28 EnjuParser_T27 EnjuParser_T29 arg1Of inhibitors,been
EnjuParser_R29 EnjuParser_T30 EnjuParser_T29 arg2Of approved,been
EnjuParser_R30 EnjuParser_T34 EnjuParser_T30 arg1Of and,approved
EnjuParser_R31 EnjuParser_T27 EnjuParser_T30 arg2Of inhibitors,approved
EnjuParser_R32 EnjuParser_T34 EnjuParser_T31 arg2Of and,by
EnjuParser_R33 EnjuParser_T34 EnjuParser_T32 arg1Of and,the
EnjuParser_R34 EnjuParser_T33 EnjuParser_T34 arg1Of Food,and
EnjuParser_R35 EnjuParser_T36 EnjuParser_T34 arg2Of Administration,and
EnjuParser_R36 EnjuParser_T36 EnjuParser_T35 arg1Of Administration,Drug
EnjuParser_R37 EnjuParser_T34 EnjuParser_T37 arg1Of and,(
EnjuParser_R38 EnjuParser_T38 EnjuParser_T37 arg2Of FDA,(
EnjuParser_R39 EnjuParser_T39 EnjuParser_T37 arg3Of ),(
EnjuParser_R40 EnjuParser_T34 EnjuParser_T40 arg1Of and,for
EnjuParser_R41 EnjuParser_T42 EnjuParser_T40 arg2Of therapy,for
EnjuParser_R42 EnjuParser_T42 EnjuParser_T41 arg1Of therapy,anticancer